Reata Pharmaceuticals Inc
RETADelisted Sep 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001358762
Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.
Members of Congress who traded RETA
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | 2 | 1 / 1 | $16.0K | Jan 4, 2021 | Feb 17, 2021 |
Trades
Every reported trade in Reata Pharmaceuticals Inc, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | RETAReata Pharmaceuticals, Inc. - Class A | Sell | Self | Jan 4, 2021 | Feb 17, 2021 | 44 days | $1K-$15K | Filing |
| Chris JacobsRepublican · House · NY | RETAReata Pharmaceuticals, Inc. - Class A | Buy | Self | Dec 28, 2020 | Feb 10, 2021 | 44 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.